Rethinking Sustainability Through Our Silk-Based Biomedical Products this #WorldEnvironmentDay!
At Serigen, we harness the healing power of silk, a naturally derived biomaterial that supports biocompatibility, better patient outcomes & sustainability!
#circulareconomy
From weekly mentoring sessions to now engaging directly with the European innovation ecosystem, BFI VK Connect has officially entered its immersion phase in Barcelona.
Over the past few months, the programme has supported some of India’s most promising healthcare startups through expert sessions, mentorship, market validation and internationalisation strategy development.
Now, the selected startups are on ground in Europe, connecting with mentors, healthcare stakeholders, innovation hubs and industry experts to better understand the European healthcare market and explore pathways for global expansion.
This immersion phase is about creating meaningful exposure and helping Indian healthcare innovators build the networks, insights and market understanding needed to scale beyond borders.
Congratulations to all the awardees of a grant from the US India Science and Technology Endowment Fund.
Happy to see Dr Rucha Deshpande from @Serigen4 in the pictures and Serigen amongst the awardees.
Meet us in #Spain! Dr. @swati_shukl, our Co-founder & COO, is looking forward to meeting clinicians, researchers, investors, industry partners & innovators interested in shaping the future of tissue engineering
📍 Barcelona
📅 25 May – 5 Jun
📩 Book a meet: [email protected]
Advancing bone regeneration through Indo-US collaboration!
Serigen is partnering with the University of Mississippi Medical Center @UMMCnews, with support from the Indo U.S. Science and Technology Forum @INDOUSSTF grant program, to develop a next-gen variant of Serioss.
A sincere thank you to our US-based mentors, collaborators, and supporters for their continued guidance and encouragement throughout this journey.
Special thanks to Amol Janorkar and the UMMC team driving this vision forward!
@AnuyaNisal@premnathv6@swati_shukl
Breakthrough healthcare technologies are rarely built in isolation. Serioss, our next-gen bone void filler, has been shaped through the collaborative power of the 𝗧𝗿𝗶𝗽𝗹𝗲 𝗛𝗲𝗹𝗶𝘅, where Government, Academia & Industry worked together to accelerate clinical innovation.
Proud of the @Serigen4 team and leadership of @AnuyaNisal and Swati Shukla as they hit impt milestones. Great progress towards the launch of India's first and pioneering bone tissue engineering product.
@csir_ncl
Serioss is a next-gen silk protein–based bone void filler engineered to mimic bone architecture and support osteoconductive repair. After years of rigorous research & randomised control clinical trials, we invite clinicians to lead the early adoption of Serioss in their practice!
From scientific breakthrough to large-scale production. Our next big milestone is almost here!
Here’s a first look at our soon-to-be-launched Serioss manufacturing facility equipped with ISO Class 7 & Class 8 cleanrooms
@AnuyaNisal@premnathv6@swati_shukl@csir_ncl@BIRAC_2012
Ready, Set, Innovate: Accelerating better healing outcomes with strong #IntellectualProperty!
This #WorldIPDay, we celebrate the IP that backs our technology & brands:
- 4 patent families
- 12 granted patents
- 10 trademarks
Proud to be an IP-driven, inventive products company!